Marc Chowrimootoo

Hayfin Capital Management LLP (Investment Management) (Hayfin-IM) is the investment management division of Hayfin Capital Management LLP, itself a subsidiary of BC Investment Management Corp. in Canada. The firm was founded by Timothy Flynn and Mark Tognolini in 2009. Headquartered in London, Hayfin-IM manages strategy-specific commingled funds and tailored separate and managed accounts which combine product exposures.

Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT.

SMBC Nikko Capital Markets Ltd. provides security exchange and investment and business advisory services. It offers professional advice, underwriting and distribution across a range of products including IPOs, follow-on transactions, convertible bonds, rights issues and block trade services. The company was founded in 1989 and is headquartered in London, the United Kingdom.

CORDET Capital Partners LLP (CORDET Capital Partners) is a private equity firm founded in 2013. The firm is headquartered in London, United Kingdom.

Reaction Capital (Reaction) is a venture capital firm founded in 2019. The firm is headquartered in Palo Alto, California.

Paradigm Spine LLC designs, develops and markets solutions for the treatment of spinal conditions and diseases. It offers solutions for the disease management of spinal stenosis. The company was founded by by Marc R. Viscogliosi, Anthony G. Viscogliosi, John J. Viscogliosi and Guntmar H. Eisen in 2004 and is headquartered in New York, NY.

Small Bone Innovations, Inc. develops and markets implants for the small bones and joints. It offers Star Ankle, A3 fusion nail, Auto fix stainless steel, Stafix, mini rail system, Fusifix, Silicon pip, Stability sigmoid notch, Rhead, Uni-Elbow radio capitellum and Autofix. The company was founded by Anthony G. Viscogliosi, John L. Viscogliosi, and Marc R. Viscogliosi in May 2004 and is headquartered in Morrisville, PA.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

MedAvante, Inc. provides signal detection solutions in clinical trials of treatments for central nervous system disorders. It offers Virgil investigative study platform for site-based assessments; and MedAvante central ratings for live assessments. The firm also offers scientific risk reduction services. The company was founded by Paul M. Gilbert, Amy Ellis, Peter B. Tilles, Livingston Johnson and Avik Roy in 2002 and is headquartered in Hamilton, NJ.

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade.

Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis.

G Square Healthcare Private Equity LLP (G Square Healthcare) is a private equity firm founded in 2008 by Laurent Gerard Ganem. The firm is headquartered in London, United Kingdom.

Sullivan & Cromwell LLP provides legal services. It specializes in the areas of corporate law, securities, corporate, litigation, mergers, real estate, pro bono, investment management and taxation. Their clients include industrial, commercial, financial, private funds, governmental, educational, charitable and cultural enterprises and entities. The company was founded by Algernon Sydney Sullivan and William Nelson Cromwell in 1879 and is headquartered in New York City, NY.